Mucosal Delivery of ACNPV Baculovirus Driving Expression of the Gal-Lectin LC3 Fragment Confers Protection against Amoebic Liver Abscess in Hamster

Mucosal vaccination against amoebiasis using the Gal-lectin of E. histolytica has been proposed as one of the leading strategies for controlling this human disease. However, most mucosal adjuvants used are toxic and the identification of safe delivery systems is necessary. Here, we evaluate the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Meneses-Ruiz, DM, Laclette, JP, Aguilar-Díaz, H, Hernández-Ruiz, J, Luz-Madrigal, A, Sampieri, A, Vaca, L, Carrero, JC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221370/
https://www.ncbi.nlm.nih.gov/pubmed/22110386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221370/
https://www.ncbi.nlm.nih.gov/pubmed/22110386

Ejemplares similares